Qube Research & Technologies (QRT)’s Zomedica Corp. ZOM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36,724	Closed	-$6.14K	–	4940
2023 Q3	$6.14K	Sell	36,724 -30,121	-45%	-$5.85K	﹤0.01%	3413
2023 Q2	$13.4K	Sell	66,845 -240,020	-78%	-$48.7K	﹤0.01%	2194
2023 Q1	$65K	Buy	306,865 +119,591	+64%	+$29.3K	﹤0.01%	2193
2022 Q4	$30.5K	Buy	187,274 +175,521	+1,493%	+$36K	﹤0.01%	2196
2022 Q3	$2K	Sell	11,753 -485,035	-98%	-$128K	﹤0.01%	2433
2022 Q2	$109K	Buy	+496,788	New	+$126K	﹤0.01%	1917
2021 Q2	–	Sell	-57,486	Closed	-$91K	–	3039
2021 Q1	$91K	Buy	+57,486	New	+$93.9K	﹤0.01%	1746

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ZOM Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Zomedica Corp. (ZOM) in Q4 2023, closing a stake of 36,724 shares — an estimated $6.14K sold.

Qube Research & Technologies (QRT) first reported a position in ZOM in Q1 2021 and held it in 7 quarters. The position peaked at $109K in Q2 2022. 92 funds tracked by Wall St. Rank hold ZOM as of Q4 2023.

Qube Research & Technologies (QRT) reported no remaining Zomedica Corp. position as of Q4 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 36,724 Zomedica Corp. shares in Q4 2023, an estimated $6.14K.
Qube Research & Technologies (QRT) first reported a position in Zomedica Corp. in Q1 2021 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Zomedica Corp. position peaked at $109K in Q2 2022.
92 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.